Management of papillary thyroid microcarcinoma

JP Brito, ID Hay - Endocrinology and Metabolism Clinics, 2019 - endo.theclinics.com
The incidence of thyroid cancer has increased worldwide. In the United States, thyroid
cancer incidence has tripled over the last 3 decades from 4.9 to 14.7 per 100,000 people in …

[HTML][HTML] Cell component and function of tumor microenvironment in thyroid cancer

E Shin, JS Koo - International journal of molecular sciences, 2022 - mdpi.com
Thyroid cancer is the most common cancer in the endocrine system. Most thyroid cancers
have good prognosis, but some of them are resistant to treatment or show aggressive …

Efficacy and safety of thermal ablation for solitary T1bN0M0 papillary thyroid carcinoma: a multicenter study

XJ Cao, J Liu, YL Zhu, L Qi, G Liu… - The Journal of …, 2021 - academic.oup.com
Background Ultrasound-guided thermal ablation plays an important role in the management
of thyroid disease. The objective of this study was to evaluate the feasibility, efficacy, and …

Time to separate persistent from recurrent differentiated thyroid cancer: different conditions with different outcomes

G Sapuppo, M Tavarelli, A Belfiore… - The Journal of …, 2019 - academic.oup.com
Context Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of
patients with DTC have disease events after initial treatment, indistinctly defined as …

Advancements in the treatment of differentiated thyroid cancer

LA Stewart, JH Kuo - Therapeutic Advances in …, 2021 - journals.sagepub.com
Derived from follicular epithelial cells, differentiated thyroid cancer (DTC) accounts for the
majority of thyroid malignancies. The threefold increase in DTC incidence over the last three …

[HTML][HTML] Advances in Antioxidant Applications for Combating 131I Side Effects in Thyroid Cancer Treatment

L Yang, J Ma, P Lei, J Yi, Y Ma, Z Huang, T Wang… - Toxics, 2023 - mdpi.com
Thyroid cancer is the most common endocrine cancer, and its prevalence has been
increasing for decades. Approx. 95% of differentiated thyroid carcinomas are treated using …

Scrutinizing the therapeutic and diagnostic potential of nanotechnology in thyroid cancer: Edifying drug targeting by nano-oncotherapeutics

E Ghazy, A Kumar, M Barani, I Kaur, A Rahdar… - Journal of Drug Delivery …, 2021 - Elsevier
The dearth of potential of diagnostic and treatment methods hinders the fight against tumors.
The advances in nanotechnology are emerging, expressing countless latent applications …

[HTML][HTML] The safety, benefits and future development of overnight and outpatient thyroidectomy

D Su, Z Zhang, F Xia, X Li - Frontiers in Endocrinology, 2023 - frontiersin.org
With the development of medical care, the safety of thyroidectomy is improving year by year.
Due to economic benefits and other advantages of the overnight and outpatient …

[HTML][HTML] Metabolic reprogramming of thyroid cancer cells and crosstalk in their microenvironment

L Bao, T Xu, X Lu, P Huang, Z Pan, M Ge - Frontiers in Oncology, 2021 - frontiersin.org
Metabolism differs significantly between tumor and normal cells. Metabolic reprogramming
in cancer cells and metabolic interplay in the tumor microenvironment (TME) are important …

[HTML][HTML] Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect

X Li, H Zheng, C Ma, Y Ji, X Wang, D Sun… - Frontiers in …, 2024 - frontiersin.org
Objective This retrospective study aims to evaluate the therapeutic effect of varying dosages
of adjuvant radioactive iodine (RAI) therapy on intermediate-risk papillary thyroid carcinoma …